Global Muscle Relaxant Drugs Market 2017-2021

筋弛緩薬の世界市場2017-2021

◆タイトル:Global Muscle Relaxant Drugs Market 2017-2021
◆商品コード:IRTNTR12170
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年3月7日
◆ページ数:70
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、筋弛緩薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、筋弛緩薬の世界市場規模及び予測、製品別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

ABSTRACTAbout Muscle Relaxant Drugs

Muscle spasticity is caused by damage to the spinal cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral palsy, and stroke can interfere with normal muscle relaxation, leading to involuntary muscle spasms. This will impair the ability to walk, work, sleep, or just function normally. The muscles can also become excessively tense and develop overactive or overresponsive reflexes. Severe cases can lead to deep disability, including an inability to straighten out joints.

Technavio’s analysts forecast the global muscle relaxant drugs market to grow at a CAGR of 5.64% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global muscle relaxant drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Muscle Relaxant Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Pfizer
• Ipsen Group
• Allergan
• Novartis
• Teva Pharmaceuticals

[Other prominent vendors]
• Acorda Therapeutics
• Aldeyra Therapeutics
• Canbex Therapeutics
• Daewoong
• Emcure Pharmaceuticals
• Endo International
• Fresenius Kabi
• Galderma
• INSYS Therapeutics
• Johnson & Johnson
• Lannett Company
• Merz Pharma
• Mylan
• Par Pharmaceutical
• PhytoTech Therapeutics
• Revance Therapeutics
• Sun Pharmaceutical Industries
• Takeda Pharmaceutical

[Market driver]
• Presence of a large patient pool driving adoption rates.
• For a full, detailed list, view our report

[Market challenge]
• Side effects associated with use of muscle relaxants hamper adoption rates.
• For a full, detailed list, view our report

[Market trend]
• Advanced drug delivery technologies fuels adoption of muscle relaxants.
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: An overview of muscle spasticity and spasms

PART 06: Pipeline landscape

PART 07: Market landscape
• Market overview
• Five forces analysis

PART 08: Market segmentation by product category
• Skeletal muscle relaxant drugs
• Facial muscle relaxant drugs

PART 09: Geographical segmentation
• Muscle relaxant drugs market in Americas
• Muscle relaxant drugs market in EMEA
• Muscle relaxant drugs market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 12: Market trends
• Anti-aging treatments driving adoption of facial relaxants
• Advanced drug delivery technologies fuels adoption of muscle relaxants
• Growing use of muscle relaxants in new indications and applications

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• Pfizer
• Allergan
• Ipsen Group
• Teva Pharmaceuticals
• Novartis
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Key muscle relaxants
Exhibit 02: Pipeline landscape
Exhibit 03: Global muscle relaxant drugs market snapshot
Exhibit 04: Global muscle relaxant drugs market 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis in global muscle relaxant drugs market
Exhibit 06: Five forces analysis
Exhibit 07: Global muscle relaxant drugs market by product category 2016
Exhibit 08: Global skeletal muscle relaxant drugs market 2016-2021 ($ millions)
Exhibit 09: Global facial muscle relaxant drugs market 2016-2021 ($ millions)
Exhibit 10: Global muscle relaxant drugs market by geography 2016 and 2021
Exhibit 11: Global muscle relaxant drugs market revenue by geography 2016-2021 ($ millions)
Exhibit 12: Market scenario in Americas
Exhibit 13: Muscle relaxant drugs market in Americas 2016-2021 ($ millions)
Exhibit 14: Market scenario in EMEA
Exhibit 15: Muscle relaxant drugs market in EMEA 2016-2021 ($ millions)
Exhibit 16: Market scenario in APAC
Exhibit 17: Muscle relaxant drugs market in APAC 2016-2021 ($ millions)
Exhibit 18: Key approvals for new indications
Exhibit 19: Key factors driving the market growth
Exhibit 20: Impact of drivers
Exhibit 21: Impact of challenges
Exhibit 22: Competitive structure analysis of global muscle relaxant drugs market 2016
Exhibit 23: Competitive analysis of global muscle relaxant drugs market
Exhibit 24: Strategic success factors of companies in global muscle relaxant drugs market
Exhibit 25: Pfizer: Strength assessment
Exhibit 26: Pfizer: Strategy assessment
Exhibit 27: Pfizer: Opportunity assessment
Exhibit 28: Allergan: Key highlights
Exhibit 29: Allergan: Strength assessment
Exhibit 30: Allergan: Strategy assessment
Exhibit 31: Allergan: Opportunity assessment
Exhibit 32: Ipsen Group: Key highlights
Exhibit 33: Ipsen Group: Strength assessment
Exhibit 34: Ipsen Group: Strategy assessment
Exhibit 35: Ipsen Group: Opportunity assessment
Exhibit 36: Teva Pharmaceuticals: Strength assessment
Exhibit 37: Teva Pharmaceuticals: Strategy assessment
Exhibit 38: Teva Pharmaceuticals: Opportunity assessment
Exhibit 39: Novartis: Strength assessment
Exhibit 40: Novartis: Strategy assessment
Exhibit 41: Novartis: Opportunity assessment



【掲載企業】

Pfizer, Ipsen Group, Allergan, Novartis, Teva Pharmaceuticals, Acorda Therapeutics, Aldeyra Therapeutics, Canbex Therapeutics, Daewoong, Emcure Pharmaceuticals, Endo International, Fresenius Kabi, Galderma, INSYS Therapeutics, Johnson & Johnson, Lannett Company, Merz Pharma, Mylan, Par Pharmaceutical, PhytoTech Therapeutics, Revance Therapeutics, Sun Pharmaceutical Industries, and Takeda Pharmaceutical.

【資料のキーワード】

筋弛緩薬、筋弛緩剤

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[筋弛緩薬の世界市場2017-2021] (Global Muscle Relaxant Drugs Market 2017-2021 / IRTNTR12170)販売に関する免責事項
[筋弛緩薬の世界市場2017-2021] (Global Muscle Relaxant Drugs Market 2017-2021 / IRTNTR12170)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆